Celularity Inc (CELU) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Celularity Inc   (NASDAQ: CELU)


Celularity Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Celularity Inc's ROI in the first quarter of 2026?
Celularity Inc recorded a cumulative net loss of $-71 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -199.22%.

Within the Healthcare sector 785 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 4256 to 4900.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -47.01 % -28.99 % -9.27 % -14.13 % -34.02 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 16 27 49 51 70
Return On Investment (TTM) -199.22 % -186.65 % -129.56 % -116.61 % -82.67 %
CELU's Overall Ranking # 4900 # 4256 # 4262 # 4169 # 4819
Seq. Investment Change TTM -27.43 % -21.04 % -1.48 % -6.14 % -2.74 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -71 -92 -81 -74 -56

CELU Company Profile >> Back to CELU Roi Comparisons >> See Annual CELU Return On Investment



Return On Investment CELU's Ranking
Within: No.
Industry # 366
Sector # 786
Overall # 4900

Return On Investment Statistics
High Average Low
7.66 %
-150.23 %
-1295.69 %
(Jun 30 2022)   (Dec 31 2021)







Financial Statements
Celularity Inc's I. Quarter Investments $ 16 Millions CELU's Balance sheet
Celularity Inc's I. Quarter Income $ 1 Millions Quarterly CELU's Income Statement
CELU's Income by Division See CELU's Income by Division


CELU Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 27 79 77 339 388
Y / Y Investment Growth -66.37 % 3.15 % -77.41 % -12.61 % -
Net Income in Millions -92 -58 -196 14 -100
Y / Y Net Income Growth - - - - -
Annual Return On Investment -345.5 % -73.28 % -256.29 % 4.19 % -25.81 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CELU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CELU's Competitors
Subscribers only: Roi for Celularity Inc's Suppliers
Subscribers only: Return On Investment for CELU's Customers

Other Ratios
CELU's Roa CELU's Inventory Turnover Ratio CELU's Growth Rates CELU's Dividend Statistics
CELU's Profitability Ratios CELU's Asset Turnover Ratio CELU's Dividend Growth
CELU's Roe CELU's Valuation Ratios CELU's Financial Strength Ratios CELU's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-30T05:07:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.